1,1-dichloroethene increases expression ISO RGD:1550045 6480464 vinylidene chloride results in increased expression of TACC3 mRNA CTD PMID:26682919 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of TACC3 mRNA CTD PMID:30723492 17alpha-ethynylestradiol decreases expression ISO RGD:1550045 6480464 Ethinyl Estradiol results in decreased expression of TACC3 mRNA CTD PMID:17942748 17alpha-ethynylestradiol multiple interactions ISO RGD:1550045 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TACC3 mRNA CTD PMID:17942748 17alpha-ethynylestradiol affects expression ISO RGD:1550045 6480464 Ethinyl Estradiol affects the expression of TACC3 mRNA CTD PMID:17555576 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of TACC3 mRNA CTD PMID:17351261 17beta-estradiol increases expression ISO RGD:1353438 6480464 Estradiol results in increased expression of TACC3 mRNA CTD PMID:16474171 more ... 17beta-estradiol increases expression ISO RGD:1550045 6480464 Estradiol results in increased expression of TACC3 mRNA CTD PMID:19484750 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:1550045 6480464 [2 more ... CTD PMID:25510870 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO RGD:1353438 6480464 2 more ... CTD PMID:31173147 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO RGD:1550045 6480464 [2 more ... CTD PMID:25510870 2,3',4,4',5-Pentachlorobiphenyl increases expression ISO RGD:1550045 6480464 2 more ... CTD PMID:31388691 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1550045 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TACC3 mRNA CTD PMID:17942748 2-amino-2-deoxy-D-glucopyranose decreases expression EXP 6480464 Glucosamine results in decreased expression of TACC3 mRNA CTD PMID:17109745 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:23196670 3,4-methylenedioxymethamphetamine decreases expression ISO RGD:1550045 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of TACC3 mRNA CTD PMID:20188158 4-hydroxynon-2-enal increases expression ISO RGD:1550045 6480464 4-hydroxy-2-nonenal results in increased expression of TACC3 mRNA CTD PMID:19191707 4-hydroxynon-2-enal decreases expression ISO RGD:1550045 6480464 4-hydroxy-2-nonenal results in decreased expression of TACC3 mRNA CTD PMID:19191707 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of TACC3 mRNA CTD PMID:24780913 acetylsalicylic acid decreases expression ISO RGD:1353438 6480464 Aspirin results in decreased expression of TACC3 mRNA CTD PMID:15928584 aflatoxin B1 affects expression ISO RGD:1353438 6480464 Aflatoxin B1 affects the expression of TACC3 protein CTD PMID:20106945 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of TACC3 mRNA CTD PMID:23630614 , PMID:25378103 aldehydo-D-glucosamine decreases expression EXP 6480464 Glucosamine results in decreased expression of TACC3 mRNA CTD PMID:17109745 AM-251 decreases expression ISO RGD:1353438 6480464 AM 251 results in decreased expression of TACC3 mRNA CTD PMID:16500647 antirheumatic drug decreases expression ISO RGD:1353438 6480464 Antirheumatic Agents results in decreased expression of TACC3 mRNA CTD PMID:24449571 Aroclor 1254 decreases expression ISO RGD:1550045 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of TACC3 mRNA CTD PMID:23650126 arsane affects methylation ISO RGD:1353438 6480464 Arsenic affects the methylation of TACC3 gene CTD PMID:25304211 arsenic atom affects methylation ISO RGD:1353438 6480464 Arsenic affects the methylation of TACC3 gene CTD PMID:25304211 benzo[a]pyrene increases expression ISO RGD:1550045 6480464 Benzo(a)pyrene results in increased expression of TACC3 mRNA CTD PMID:20504355 , PMID:27195522 benzo[a]pyrene decreases expression ISO RGD:1550045 6480464 Benzo(a)pyrene results in decreased expression of TACC3 mRNA CTD PMID:17942131 , PMID:19770486 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1353438 6480464 7 more ... CTD PMID:19150397 more ... benzo[b]fluoranthene increases expression ISO RGD:1550045 6480464 benzo(b)fluoranthene results in increased expression of TACC3 mRNA CTD PMID:26377693 beta-D-glucosamine decreases expression EXP 6480464 Glucosamine results in decreased expression of TACC3 mRNA CTD PMID:17109745 bis(2-chloroethyl) sulfide decreases expression ISO RGD:1353438 6480464 Mustard Gas results in decreased expression of TACC3 mRNA CTD PMID:25102026 bisphenol A affects binding ISO RGD:1353438 6480464 bisphenol A binds to TACC3 protein CTD PMID:20403423 bisphenol A affects expression ISO RGD:1353438 6480464 bisphenol A affects the expression of TACC3 mRNA CTD PMID:30903817 bisphenol A decreases expression ISO RGD:1353438 6480464 bisphenol A results in decreased expression of TACC3 mRNA CTD PMID:29275510 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of TACC3 mRNA CTD PMID:25181051 , PMID:30816183 bisphenol A increases expression ISO RGD:1353438 6480464 bisphenol A results in increased expression of TACC3 mRNA CTD PMID:16474171 calcitriol decreases expression ISO RGD:1353438 6480464 Calcitriol results in decreased expression of TACC3 mRNA CTD PMID:21592394 calcitriol multiple interactions ISO RGD:1353438 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of TACC3 mRNA CTD PMID:21592394 carbamazepine affects expression ISO RGD:1353438 6480464 Carbamazepine affects the expression of TACC3 mRNA CTD PMID:25979313 carbon nanotube increases expression ISO RGD:1550045 6480464 Nanotubes, Carbon analog results in increased expression of TACC3 mRNA, Nanotubes, Carbon results in increased expression of TACC3 mRNA CTD PMID:25554681 choline multiple interactions ISO RGD:1550045 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of TACC3 gene CTD PMID:20938992 cisplatin increases expression ISO RGD:1550045 6480464 Cisplatin results in increased expression of TACC3 mRNA CTD PMID:21151649 copper atom multiple interactions ISO RGD:1353438 6480464 [NSC 689534 binds to Copper] which results in decreased expression of TACC3 mRNA CTD PMID:20971185 copper(0) multiple interactions ISO RGD:1353438 6480464 [NSC 689534 binds to Copper] which results in decreased expression of TACC3 mRNA CTD PMID:20971185 copper(II) sulfate decreases expression ISO RGD:1353438 6480464 Copper Sulfate results in decreased expression of TACC3 mRNA CTD PMID:19549813 coumestrol increases expression ISO RGD:1353438 6480464 Coumestrol results in increased expression of TACC3 mRNA CTD PMID:19167446 coumestrol multiple interactions ISO RGD:1353438 6480464 [Coumestrol co-treated with 2 more ... CTD PMID:19167446 cyclosporin A decreases expression ISO RGD:1550045 6480464 Cyclosporine results in decreased expression of TACC3 mRNA CTD PMID:17942131 cyclosporin A decreases expression ISO RGD:1353438 6480464 Cyclosporine results in decreased expression of TACC3 mRNA CTD PMID:20106945 more ... decabromodiphenyl ether decreases expression EXP 6480464 decabromobiphenyl ether results in decreased expression of TACC3 mRNA CTD PMID:23640034 diazinon affects expression EXP 6480464 Diazinon affects the expression of TACC3 mRNA CTD PMID:22546817 dibenz[a,h]anthracene increases expression ISO RGD:1550045 6480464 1 more ... CTD PMID:26377693 dibutyl phthalate decreases expression ISO RGD:1550045 6480464 Dibutyl Phthalate results in decreased expression of TACC3 mRNA CTD PMID:17361019 dichloroacetic acid increases expression ISO RGD:1550045 6480464 Dichloroacetic Acid results in increased expression of TACC3 mRNA CTD PMID:28962523 dioxygen decreases expression ISO RGD:1353438 6480464 Oxygen deficiency results in decreased expression of TACC3 mRNA CTD PMID:26516004 dorsomorphin multiple interactions ISO RGD:1353438 6480464 [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TACC3 mRNA CTD PMID:27188386 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of TACC3 mRNA CTD PMID:29391264 Enterolactone multiple interactions ISO RGD:1353438 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of TACC3 mRNA CTD PMID:19167446 enzyme inhibitor multiple interactions ISO RGD:1353438 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of TACC3 protein CTD PMID:23301498 folic acid multiple interactions ISO RGD:1550045 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of TACC3 gene CTD PMID:20938992 folic acid multiple interactions ISO RGD:1353438 6480464 [Folic Acid deficiency co-treated with Methotrexate] results in decreased expression of TACC3 mRNA CTD PMID:24657277 genistein increases expression ISO RGD:1353438 6480464 Genistein results in increased expression of TACC3 mRNA CTD PMID:16474171 hydrogen peroxide affects expression ISO RGD:1353438 6480464 Hydrogen Peroxide affects the expression of TACC3 mRNA CTD PMID:20044591 L-methionine multiple interactions ISO RGD:1550045 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of TACC3 gene CTD PMID:20938992 lead(0) affects expression ISO RGD:1353438 6480464 Lead affects the expression of TACC3 mRNA CTD PMID:28903495 lead(2+) affects expression ISO RGD:1353438 6480464 Lead affects the expression of TACC3 mRNA CTD PMID:28903495 leflunomide decreases expression ISO RGD:1353438 6480464 leflunomide results in decreased expression of TACC3 mRNA CTD PMID:28988120 methotrexate multiple interactions ISO RGD:1353438 6480464 [Folic Acid deficiency co-treated with Methotrexate] results in decreased expression of TACC3 mRNA CTD PMID:24657277 methylmercury chloride increases expression ISO RGD:1353438 6480464 methylmercuric chloride results in increased expression of TACC3 mRNA CTD PMID:26272509 methylmercury chloride multiple interactions ISO RGD:1353438 6480464 [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TACC3 mRNA CTD PMID:27188386 Niclosamide decreases expression ISO RGD:1353438 6480464 Niclosamide results in decreased expression of TACC3 mRNA CTD PMID:28284560 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of TACC3 mRNA CTD PMID:25729387 ozone multiple interactions ISO RGD:1550045 6480464 TTPA protein affects the reaction [Ozone results in increased expression of TACC3 mRNA] CTD PMID:19555225 ozone increases expression ISO RGD:1550045 6480464 Ozone results in increased expression of TACC3 mRNA CTD PMID:25658374 ozone decreases expression ISO RGD:1550045 6480464 Ozone results in decreased expression of TACC3 mRNA CTD PMID:24336422 paclitaxel decreases expression ISO RGD:1353438 6480464 Paclitaxel results in decreased expression of TACC3 protein CTD PMID:15907983 paracetamol decreases expression ISO RGD:1550045 6480464 Acetaminophen results in decreased expression of TACC3 mRNA CTD PMID:17942131 paracetamol increases expression ISO RGD:1353438 6480464 Acetaminophen results in increased expression of TACC3 mRNA CTD PMID:22230336 phenobarbital multiple interactions ISO RGD:1550045 6480464 NR1I3 protein affects the reaction [Phenobarbital results in increased expression of TACC3 mRNA] CTD PMID:19482888 phenobarbital affects expression ISO RGD:1550045 6480464 Phenobarbital affects the expression of TACC3 mRNA CTD PMID:19136022 , PMID:23091169 phenobarbital increases expression ISO RGD:1550045 6480464 Phenobarbital results in increased expression of TACC3 mRNA CTD PMID:19482888 pirinixic acid affects expression ISO RGD:1550045 6480464 pirinixic acid affects the expression of TACC3 mRNA CTD PMID:19136022 pirinixic acid increases expression ISO RGD:1550045 6480464 pirinixic acid results in increased expression of TACC3 mRNA CTD PMID:17950772 more ... pirinixic acid multiple interactions ISO RGD:1550045 6480464 PPARA protein affects the reaction [pirinixic acid results in increased expression of TACC3 mRNA], PPARA protein promotes the reaction [pirinixic acid results in increased expression of TACC3 mRNA] CTD PMID:17950772 , PMID:21318169 pregnenolone 16alpha-carbonitrile increases expression ISO RGD:1550045 6480464 Pregnenolone Carbonitrile results in increased expression of TACC3 mRNA CTD PMID:22698814 resveratrol multiple interactions ISO RGD:1353438 6480464 [Coumestrol co-treated with resveratrol] results in increased expression of TACC3 mRNA CTD PMID:19167446 rotenone decreases expression ISO RGD:1353438 6480464 Rotenone results in decreased expression of TACC3 mRNA CTD PMID:29955902 SB 431542 multiple interactions ISO RGD:1353438 6480464 [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TACC3 mRNA CTD PMID:27188386 silver atom decreases expression ISO RGD:1353438 6480464 Silver results in decreased expression of TACC3 mRNA CTD PMID:26551752 silver(0) decreases expression ISO RGD:1353438 6480464 Silver results in decreased expression of TACC3 mRNA CTD PMID:26551752 sodium arsenite increases expression ISO RGD:1353438 6480464 sodium arsenite results in increased expression of TACC3 mRNA CTD PMID:28595984 , PMID:29301061 sunitinib decreases expression ISO RGD:1353438 6480464 Sunitinib results in decreased expression of TACC3 mRNA CTD PMID:31533062 tamoxifen affects expression ISO RGD:1550045 6480464 Tamoxifen affects the expression of TACC3 mRNA CTD PMID:17555576 testosterone multiple interactions ISO RGD:1353438 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of TACC3 mRNA CTD PMID:21592394 testosterone decreases expression ISO RGD:1353438 6480464 Testosterone results in decreased expression of TACC3 mRNA CTD PMID:21592394 tetrachloromethane affects expression ISO RGD:1550045 6480464 Carbon Tetrachloride affects the expression of TACC3 mRNA CTD PMID:17484886 tetrachloromethane increases expression ISO RGD:1550045 6480464 Carbon Tetrachloride results in increased expression of TACC3 mRNA CTD PMID:27339419 , PMID:29987408 titanium dioxide increases expression ISO RGD:1550045 6480464 titanium dioxide results in increased expression of TACC3 mRNA CTD PMID:23557971 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of TACC3 mRNA CTD PMID:25729387 Tributyltin oxide decreases expression ISO RGD:1550045 6480464 bis(tri-n-butyltin)oxide results in decreased expression of TACC3 mRNA CTD PMID:17942131 , PMID:18958704 trichloroethene increases expression ISO RGD:1550045 6480464 Trichloroethylene results in increased expression of TACC3 mRNA CTD PMID:25549359 trimellitic anhydride increases expression ISO RGD:1550045 6480464 trimellitic anhydride results in increased expression of TACC3 mRNA CTD PMID:19042947 tunicamycin decreases expression ISO RGD:1353438 6480464 Tunicamycin results in decreased expression of TACC3 mRNA CTD PMID:22378314 , PMID:29453283 valproic acid increases methylation ISO RGD:1353438 6480464 Valproic Acid results in increased methylation of TACC3 gene CTD PMID:29154799 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of TACC3 mRNA CTD PMID:23555832 zoledronic acid decreases expression ISO RGD:1353438 6480464 zoledronic acid results in decreased expression of TACC3 mRNA CTD PMID:24714768
Gene-Chemical Interaction Annotations
